News
Innovating Neuropathy Treatment: The Pharmaceutical Pursuit of Enhanced Oxygen Delivery
Strategies that address tissue hypoxia and metabolic dysfunction at a cellular level are increasingly shaping neuropathy treatment. Among these, hyperbaric oxygen therapy nerve regeneration has emerged as a focal point for pharmaceutical innovation. As industry stakeholders seek scalable, mechanism-driven...
News
Optimizing the Mobile Pharma Workforce: Ergonomics as a Driver of Productivity and Data Integrity
Ergonomics should be a top priority for any organization undergoing digital transformation in the pharmaceutical industry. Integrating mobile health into your operations can revolutionize patient recruitment and retention in clinical trials, medication adherence, real-time data collection and monitoring, and...
Clinical Trials
FDA Outlines Genome Editing Safety Guidance for Therapies
The U.S. Food and Drug Administration has released a draft guidance outlining safety assessment standards for human gene therapy products that incorporate genome editing technologies, marking a step toward streamlining development pathways for advanced therapies. Announced on April 14,...
Drug Research
AWS Unveils Amazon Bio Discovery to Accelerate Drug Research
Amazon Web Services has introduced Amazon Bio Discovery, an AI-powered application designed to streamline drug research by enabling scientists to design, test, and refine novel therapies with greater speed and precision. The platform leverages biological foundation models trained on...
Business & Industry
Lilly Acquires CrossBridge to Expand Next-Gen ADC Pipeline
Eli Lilly and Company has entered into an agreement to acquire all outstanding shares of CrossBridge Bio in a transaction valued at up to $300m, structured through an upfront payment and additional milestone-based compensation linked to development progress. The...
Business & Industry
AbbVie Secures $745M Haisco Deal to Expand Pain Drug Pipeline
AbbVie has entered into a global licensing agreement with China-based Haisco Pharmaceutical valued at up to $715 million, aiming to strengthen its presence in pain therapeutics. The Haisco deal grants AbbVie exclusive rights to develop, manufacture, and commercialize multiple...
Business & Industry
Aragen ChemiSHE Lab Launch Strengthens Women in Pharma R&D
Aragen has introduced ChemiSHE, positioning it as India’s first chemistry synthesis laboratory fully operated and led by women scientists. The facility was inaugurated on 8 April 2026 at the company’s Mallapur campus in Hyderabad, marking a targeted step by...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read